HY-100013A1-10mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-100013A1-25mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-100013A1-5mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-100013A1-50mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-100303-1mg
|
MedChemexpress LLC
|
FR194738 free base [CAS 204067-45-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-100303-10mg
|
MedChemexpress LLC
|
FR194738 free base [CAS 204067-45-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-100303-100mg
|
MedChemexpress LLC
|
FR194738 free base [CAS 204067-45-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-100303-25mg
|
MedChemexpress LLC
|
FR194738 free base [CAS 204067-45-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-100303-5mg
|
MedChemexpress LLC
|
FR194738 free base [CAS 204067-45-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-100303-50mg
|
MedChemexpress LLC
|
FR194738 free base [CAS 204067-45-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-10126-10mg
|
MedChemexpress LLC
|
Barasertib-HQPA [CAS 722544-51-6]
|
|
Cancer-Kinase/protease
|
|
HY-10126-100mg
|
MedChemexpress LLC
|
Barasertib-HQPA [CAS 722544-51-6]
|
|
Cancer-Kinase/protease
|
|
HY-10126-5mg
|
MedChemexpress LLC
|
Barasertib-HQPA [CAS 722544-51-6]
|
|
Cancer-Kinase/protease
|
|
HY-10126-50mg
|
MedChemexpress LLC
|
Barasertib-HQPA [CAS 722544-51-6]
|
|
Cancer-Kinase/protease
|
|
HY-10127-10mg
|
MedChemexpress LLC
|
Barasertib [CAS 722543-31-9]
|
|
Cancer-Kinase/protease
|
|
HY-10127-5mg
|
MedChemexpress LLC
|
Barasertib [CAS 722543-31-9]
|
|
Cancer-Kinase/protease
|
|
HY-10127-50mg
|
MedChemexpress LLC
|
Barasertib [CAS 722543-31-9]
|
|
Cancer-Kinase/protease
|
|
HY-10130-10mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
HY-10130-100mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
HY-10130-200mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
HY-10130-5mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
HY-10130-50mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
HY-108632-1mg
|
MedChemexpress LLC
|
BYK204165 [CAS 1104546-89-5]
|
|
Cancer-programmed cell death
|
|
HY-108632-10mg
|
MedChemexpress LLC
|
BYK204165 [CAS 1104546-89-5]
|
|
Cancer-programmed cell death
|
|
HY-108632-25mg
|
MedChemexpress LLC
|
BYK204165 [CAS 1104546-89-5]
|
|
Cancer-programmed cell death
|
|